Cobre Ltd (CBE) ORDINARY FULLY PAID |
Materials |
$19 |
Underwritten Loyalty Options Prospectus
|
13 Jun 2025 10:31AM |
$0.046 |
$0.043 |
fallen by
6.52%
|
|
CBE - Price-sensitive ASX Announcement
Full Release
Key Points
- Cobre Limited is offering up to 91,060,961 new options to eligible shareholders via an underwritten pro-rata non-renounceable loyalty option issue.
- Eligible shareholders will receive one new option for every ten shares held as at the record date, with options issued for free.
- Each option is exercisable at $0.08 and expires on 30 June 2026.
- If all options are exercised, the company could raise up to approximately $7.28 million before costs.
- Funds raised will be used for exploration and development activities, working capital, and costs of the offer.
- The offer is fully underwritten by Canaccord Genuity (Australia) Limited.
- The prospectus includes details on eligibility, option terms, risks, company background, and legal disclosures.
- Directors and management hold significant interests in the company and may participate in the offer.
- The document discusses potential risks such as exploration risks, commodity price volatility, and dilution for existing shareholders.
- The offer is only available to eligible shareholders with registered addresses in Australia or New Zealand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Cobre Ltd (CBE) ORDINARY FULLY PAID |
Materials |
$19 |
Placement and Fully Underwritten Loyalty Options Offer
|
13 Jun 2025 10:30AM |
$0.046 |
$0.043 |
fallen by
6.52%
|
|
CBE - Price-sensitive ASX Announcement
Full Release
Key Points
- Cobre Ltd is undertaking a Placement to raise approximately A$5.7 million from institutional and sophisticated investors.
- A fully underwritten Loyalty Options Offer is being made to all eligible existing Cobre shareholders on the record date.
- Funds raised will be used primarily for an extensive drilling program at the Ngami Copper Project (NCP) in Botswana.
- The drilling campaign aims to define a maiden Mineral Resource at NCP within the Kalahari Copper Belt.
- Placement shares will be issued at $0.06 per share, representing a discount to recent trading prices.
- Shareholders participating in the Loyalty Options Offer will receive one free option for every three shares held.
- The Loyalty Options will have an exercise price of $0.10 per share and an expiry date of 30 June 2026.
- The offer is fully underwritten by Canaccord Genuity (Australia) Limited.
- Key dates, offer terms, and capital structure implications are outlined in the document.
- Directors and management involved in the Placement, showing a strong alignment with shareholders.
- The capital raising supports Cobre's growth strategy and commitment to delivering value through exploration success.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$8 |
EQR Progresses Regional Tungsten Hub Strategy
|
13 Jun 2025 10:28AM |
$0.120 |
$0.096 |
fallen by
20%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Invion Limited updates on the IVX platform's research and collaboration progress.
- EQR progresses its regional tungsten hub strategy with new exploration milestones.
- Strategic partnerships are being formed to support project development.
- Recent exploration results support the viability of the tungsten hub.
- The announcement reiterates commitment to advancing innovation and market presence.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$3 |
Change in Director Interest Notice (IR & DF)
|
13 Jun 2025 10:27AM |
$0.003 |
$0.003 |
risen by
20%
|
|
WCM Global Growth Limited (WQG) ORDINARY FULLY PAID |
Financials |
$429 |
Renewal of Existing On-Market Share Buy-Back
|
13 Jun 2025 10:25AM |
$1.780 |
$1.890 |
risen by
6.18%
|
|
WQG - Price-sensitive ASX Announcement
Full Release
Key Points
- WCM Global Growth Limited (WQG) announced the renewal of its on-market share buy-back.
- The buy-back permits purchasing up to 10% of issued shares over a 12-month period from 15 July 2024.
- Purpose of the buy-back is for capital management and to return capital to shareholders.
- Buy-back supports shareholders, especially when the share price is at a discount to NTA.
- The company is well-capitalised and the buy-back will not affect investment objectives or obligations.
- Actual shares to be bought back depend on market conditions and board discretion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$4,228 |
Notification regarding unquoted securities - AMP
|
13 Jun 2025 10:23AM |
$1.228 |
$1.670 |
risen by
36.05%
|
|
Select Harvests Limited (SHV) ORDINARY FULLY PAID |
Consumer Staple |
$507 |
Change of Director's Interest Notice (David Surveyor)
|
13 Jun 2025 10:20AM |
$4.515 |
$3.570 |
fallen by
20.93%
|
|
WAM Alternative Assets Limited (WMA) ORDINARY FULLY PAID |
Financials |
$198 |
May 2025 Investment Update
|
13 Jun 2025 10:15AM |
$0.975 |
$1.005 |
risen by
3.08%
|
|
Whitefield Industrials Limited (WHF) ORDINARY FULLY PAID |
Financials |
$704 |
Net Tangible Asset Backing - May 25
|
13 Jun 2025 10:13AM |
$5.690 |
$5.840 |
risen by
2.64%
|
|
Champion Iron Limited (CIA) ORDINARY FULLY PAID |
Materials |
$2,245 |
Change of Director's Interest Notice - David Cataford
|
13 Jun 2025 10:12AM |
$4.175 |
$4.210 |
risen by
0.84%
|
|
ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$293 |
Proposed issue of securities - INR
|
13 Jun 2025 10:11AM |
$0.115 |
$0.110 |
fallen by
4.35%
|
|
Alternative Investment Trust (AIQ) ORDINARY UNITS FULLY PAID |
Financials |
$59 |
Net Tangible Asset Backing May 2025
|
13 Jun 2025 10:11AM |
$1.510 |
$1.850 |
risen by
22.52%
|
|
NH3 Clean Energy Limited (NH3) ORDINARY FULLY PAID |
Materials |
$38 |
Investor Webinar Presentation
|
13 Jun 2025 10:10AM |
$0.035 |
$0.060 |
risen by
71.43%
|
|
NH3 - Price-sensitive ASX Announcement
Full Release
Key Points
- NH3 Clean Energy Limited is focused on ammonia (NH3) as a carbon-free energy carrier and fuel.
- The company has developed proprietary technology for efficient ammonia cracking to release hydrogen.
- NH3 is highlighted as a safe, cost-effective, and scalable solution for hydrogen transport and storage.
- NH3 Clean Energy targets the decarbonization of hard-to-abate sectors such as shipping, industry, and power generation.
- The presentation outlines significant market opportunities due to global commitments to reduce carbon emissions.
- The company's business model includes product sales, licensing, and partnership-driven deployment.
- NH3 Clean Energy is progressing through technology validation, pilot projects, and early commercial deployments.
- Strategic partnerships with industry leaders and research institutions are central to the company's approach.
- Market drivers include tightening emission regulations, green hydrogen policies, and the need for alternative fuels.
- The document presents a commercialization roadmap, with upcoming milestones and projected financial growth.
- Investor engagement is sought to accelerate technology deployment and capture emerging market opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Adslot Ltd (ADS) ORDINARY FULLY PAID |
Information Technology |
$5 |
Change of Director's Interest Notice - A Dyer
|
13 Jun 2025 10:05AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
Champion Iron Limited (CIA) ORDINARY FULLY PAID |
Materials |
$2,245 |
Notification regarding unquoted securities - CIA
|
13 Jun 2025 10:03AM |
$4.225 |
$4.210 |
fallen by
0.36%
|
|
Pengana Capital Group Limited (PCG) ORDINARY FULLY PAID |
Financials |
$79 |
Monthly Funds Under Management- 31 May 2025
|
13 Jun 2025 10:02AM |
$0.810 |
$0.795 |
fallen by
1.85%
|
|
PCG - Price-sensitive ASX Announcement
Full Release
Key Points
- Monthly update of Pengana Capital Group's Funds Under Management (FUM) as of 31 May 2025.
- Detailed FUM breakdown by individual funds and investment strategies.
- Month-on-month comparison and calculation of FUM movement.
- Commentary provided to explain significant changes in FUM across products.
- Contact details for further information or shareholder inquiries.
- Information is directed towards shareholders and the investment community.
- Data reflects performance, inflows, and outflows for each fund during the reporting period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$293 |
Investor Presentation - Equity Raising
|
13 Jun 2025 10:00AM |
$0.115 |
$0.110 |
fallen by
4.35%
|
|
Adriatic Metals Plc (ADT) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$2,035 |
Trading Halt
|
13 Jun 2025 9:59AM |
$5.000 |
$5.890 |
risen by
17.80%
|
|
ADT - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested for Adriatic Metals Plc (ASX: ADT) effective 3 June 2024.
- The trading halt is due to a pending announcement regarding a proposed capital raising.
- Trading halt is to ensure the market remains fully informed.
- Securities will remain in pre-open until normal trading resumes or announcement is made.
- The halt will end at the earlier of the announcement release or 5 June 2024.
- The process complies with the requirements of ASX Listing Rule 17.1.
- Company provided confirmation that the trading halt is not due to any other reason.
- The halt was requested to prevent trading on an uninformed basis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
ioneer Ltd (INR) ORDINARY FULLY PAID |
Materials |
$293 |
US$16M Placement to Move Project through Partnering Process
|
13 Jun 2025 9:59AM |
$0.115 |
$0.110 |
fallen by
4.35%
|
|
INR - Price-sensitive ASX Announcement
Full Release
Key Points
- ioneer Ltd raised approximately US$16 million through an institutional placement.
- The funds will support ongoing development of the Rhyolite Ridge Lithium-Boron Project in Nevada, USA.
- The placement was well supported by both existing and new institutional investors.
- The capital will fund permitting, engineering, and strategic partnering activities.
- The company is progressing a formal partnering process for the project.
- Rhyolite Ridge is positioned as a significant source of lithium for the US supply chain.
- ioneer emphasizes sustainability, regulatory compliance, and stakeholder engagement as core project values.
- The placement strengthens ioneer's financial position as it advances towards production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$1,733 |
SABRE topline results
|
13 Jun 2025 9:58AM |
$2.340 |
$4.660 |
risen by
99.15%
|
|
CU6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Clarity Pharmaceuticals announced topline results from the SABRE trial for 64Cu-SAR-bisPSMA (CU6).
- The SABRE trial focused on men with biochemical recurrence (BCR) of prostate cancer.
- Primary endpoint was met: safety and detection of PSMA-positive lesions.
- Key secondary endpoint of sensitivity was also achieved.
- CU6 demonstrated favorable safety profile with no serious adverse events related to the product.
- High sensitivity and clear imaging of prostate cancer recurrence were demonstrated.
- Results support further clinical development and regulatory submissions.
- CU6 offers potential benefits in logistics and broader clinical adoption due to copper-64's longer half-life.
- Clarity’s proprietary Targeted Copper Theranostics platform underpins the development of CU6.
- The SABRE study results represent a significant milestone for Clarity Pharmaceuticals’ diagnostic product pipeline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Adriatic Metals Plc (ADT) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$2,035 |
Pause in Trading
|
13 Jun 2025 9:55AM |
$5.000 |
$5.890 |
risen by
17.80%
|
|
ADT - Price-sensitive ASX Announcement
Full Release
Key Points
- Adriatic Metals Plc requested a temporary pause in trading on the ASX.
- The pause is pending an upcoming material announcement.
- Trading will resume at the earlier of the announcement or at the start of trading on 24 June 2024.
- The trading halt is to ensure the market is properly informed.
- The company confirmed there are no reasons why the pause should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$8 |
Loyalty Option Entitlement Offer
|
13 Jun 2025 9:54AM |
$0.120 |
$0.096 |
fallen by
20%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Invion Limited (IVX) announces a Loyalty Option Entitlement Offer for shareholders.
- Eligible shareholders can apply for one new loyalty option for every two IVX shares held as of the record date.
- The exercise price for each loyalty option is $0.016, expiring 30 June 2025.
- The offer is non-renounceable and aims to reward existing shareholders and potentially raise capital.
- Funds raised will support ongoing research and development, especially the Photosoft technology.
- The offer includes a detailed timetable, eligibility rules, and risk factors for investors.
- Shareholders are provided with instructions for applying and information on the consequences of not participating.
- The document outlines risks associated with IVX, including business, financial, and market risks.
- Directors and substantial shareholders’ intentions regarding participation in the offer are disclosed.
- Use of proceeds includes funding clinical trials, regulatory activities, and working capital.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
hipages Group Holdings Limited (HPG) ORDINARY FULLY PAID |
Communication Services |
$127 |
Notification regarding unquoted securities - HPG
|
13 Jun 2025 9:54AM |
$0.815 |
$0.950 |
risen by
16.56%
|
|
Macarthur Minerals Limited (MIO) ORDINARY FULLY PAID |
Materials |
$3 |
Proposed issue of securities - MIO
|
13 Jun 2025 9:53AM |
$0.017 |
$0.016 |
fallen by
5.88%
|
|
Hastings Technology Metals Limited (HAS) ORDINARY FULLY PAID |
Materials |
$58 |
Final Director's Interest Notice
|
13 Jun 2025 9:52AM |
$0.295 |
$0.285 |
fallen by
3.39%
|
|